Advisor Group Holdings, Inc. Innoviva, Inc. Transaction History

Advisor Group Holdings, Inc.

$67.1 Billion
Q3 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Innoviva, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 9,185 shares of INVA stock, worth $204,366. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,185

Previous 8,700 5.57%

Holding current value

$204,366

Previous $174,000 4.02%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$18.17 - $20.92 $8,812 - $10,146	485 Added 5.57%	9,185 $167,000
Q2 2025 Sep 04, 2025	BUY	$17.1 - $21.8 $9,832 - $12,535	575 Added 7.08%	8,700 $174,000
Q2 2025 Aug 13, 2025	BUY	$17.1 - $21.8 $117,442 - $149,722	6,868 Added 546.38%	8,125 $163,000
Q1 2025 May 12, 2025	SELL	$17.21 - $18.98 $42,577 - $46,956	-2,474 Reduced 66.31%	1,257 $22,000
Q4 2024 Jun 06, 2025	BUY	$17.35 - $20.32 $45,908 - $53,766	2,646 Added 210.5%	3,903 $67,000

Q4 2024 Feb 07, 2025	BUY	$17.35 - $20.32 $7,547 - $8,839	435 Added 13.2%	3,731 $64,000
Q3 2024 Nov 13, 2024	SELL	$16.33 - $20.04 $7,479 - $9,178	-458 Reduced 12.2%	3,296 $63,000
Q2 2024 Aug 13, 2024	BUY	$14.4 - $16.4 $2,246 - $2,558	156 Added 4.34%	3,754 $61,000
Q1 2024 May 10, 2024	SELL	$14.56 - $16.78 $58,662 - $67,606	-4,029 Reduced 52.83%	3,598 $54,000
Q4 2023 Feb 12, 2024	SELL	$12.32 - $16.27 $19,342 - $25,543	-1,570 Reduced 17.07%	7,627 $122,000
Q3 2023 Nov 13, 2023	BUY	$12.37 - $13.89 $48,849 - $54,851	3,949 Added 75.25%	9,197 $119,000
Q2 2023 Aug 10, 2023	SELL	$11.39 - $13.72 $2,300 - $2,771	-202 Reduced 3.71%	5,248 $66,000
Q1 2023 May 12, 2023	BUY	$10.73 - $13.6 $12,039 - $15,259	1,122 Added 25.92%	5,450 $61,000
Q4 2022 Feb 10, 2023	SELL	$11.8 - $13.78 $75,779 - $88,495	-6,422 Reduced 59.74%	4,328 $57,000
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $70,693 - $92,674	6,089 Added 130.64%	10,750 $125,000
Q2 2022 Aug 10, 2022	SELL	$14.32 - $19.88 $49,790 - $69,122	-3,477 Reduced 42.73%	4,661 $68,000
Q1 2022 May 04, 2022	BUY	$15.39 - $20.25 $16,020 - $21,080	1,041 Added 14.67%	8,138 $153,000
Q3 2021 Nov 05, 2021	SELL	$13.06 - $17.24 $31,474 - $41,548	-2,410 Reduced 25.35%	7,097 $118,000
Q2 2021 Aug 02, 2021	BUY	$11.45 - $13.96 $23,209 - $28,296	2,027 Added 27.1%	9,507 $127,000
Q1 2021 May 13, 2021	SELL	$11.06 - $12.87 $1,094 - $1,274	-99 Reduced 1.31%	7,480 $89,000
Q4 2020 Feb 10, 2021	BUY	$9.33 - $12.48 $20,451 - $27,356	2,192 Added 40.69%	7,579 $94,000
Q3 2020 Nov 12, 2020	SELL	$10.33 - $14.49 $14,369 - $20,155	-1,391 Reduced 20.52%	5,387 $64,000
Q2 2020 Aug 14, 2020	BUY	$11.49 - $15.26 $21,026 - $27,925	1,830 Added 36.98%	6,778 $96,000
Q1 2020 May 18, 2020	BUY	$8.11 - $15.23 $40,128 - $75,358	4,948 New	4,948 $59,000

Others Institutions Holding INVA

# of Institutions

281

Shares Held

82.7M

Call Options Held

13.2K

Put Options Held

156K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.55B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Innoviva, Inc. Transaction History